NCT04344444View on ClinicalTrials.gov

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

PHASE3TerminatedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

April 13, 2020

Primary Completion Date

April 10, 2021

Study Completion Date

January 5, 2022

Conditions

COVID-19

Interventions

DRUG

Hydroxychloroquine

tablets provided as described in Arm B

DRUG

Azithromycin

tablets provided as described in Arm C

Trial Locations (1)

70112

University Medical Center New Orleans, New Orleans

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LCMC Health

OTHER

NCT04344444 - Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease | Biotech Hunter | Biotech Hunter